TUMOUR MARKER ABNORMAL

This adverse event was reported 331 times

These drugs are most commonly taken by patients reporting TUMOUR MARKER ABNORMAL:

# Drug Count
0 PALBOCICLIB 62
1 LETROZOLE 57
2 RIBOCICLIB 57
3 FULVESTRANT 53
4 LETROZOLE TABLETS 45
5 EXEMESTANE 27
6 CAPECITABINE 25
7 DENOSUMAB 24
8 ANASTROZOLE 22
9 ANASTROZOLE TABLETS 20
See all common drugs associated with TUMOUR MARKER ABNORMAL

TUMOUR MARKER ABNORMAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ZINGIBER OFFICINALE 3 0.0345
1 FERROUS FUMARATE AND POLYSACCHRIDE IRON COMPLEX AND FOLIC ACID 1 0.0104
2 DEMECLOCYCLINE 1 0.0044
3 TRASTUZUMAB-DKST 1 0.0036
4 PAMIDRONATE DISODIUM 10 0.0029
5 BODY CLEANSER 2 0.0028
6 RIBOCICLIB 57 0.0017
7 NITROFURANTOIN (MACROCRYSTALS) 1 0.0016
8 FULVESTRANT 53 0.0016
9 ELACESTRANT 11 0.0015
See all drugs enriched for association with TUMOUR MARKER ABNORMAL